Rivista di formazione e aggiornamento professionale del pediatra e del medico di base, fondata nel 1982. In collaborazione con l'Associazione Culturale Pediatri.
Login Abbonamenti Pubblicazioni Carrello Registrazione Perché registrarsi? Contatti

Caso contributivo

PDF

Esiste una relazione tra latte materno e infezione neonatale
da streptococco B?

Is there any relationship between infected breast milk and late-onset gbs disease?

Elisa Zanelli1, Serena Pastore1, Chiara Zanchi2, Laura Travan3
1UCO Clinica Pediatrica, Università di Trieste; 2SC Pediatria d’urgenza e Pronto soccorso pediatrico; 3SC Neonatologia e terapia intensive neonatale, IRCCS Materno-Infantile “Burlo Garofolo”, Trieste

Ottobre 2013

Abstract
Recurrent GBS infection represents a potentially preventable subset of late-onset GBS sepsis. It occurs in 0.5% to 3.0% of infants. Mother can represent the first source of late-onset disease (LOD) and some case reports attribute responsibility to breast milk. The paper describes a case of a septic infant who had a GBS positive blood culture and who, after appropriate antibiotic treatment, experienced relapse. At that time a bacterial culture of the expressed breast milk tested positive for GBS and the mother was treated with antibiotic therapy. As reported in literature, sometimes the suspension of breast milk does not prevent relapse, demonstrating that GBS-colonized milk is not responsible of the recurrence, but rather an epiphenomenon of LOD. However, the research of GBS on breast milk should be carried out in the late-onset neonatal sepsis and an eradicating antibiotic treatment of GBS-positive mother could prevent recurrent GBS sepsis.
Contenuto riservato

Per leggere l'articolo è necessario effettuare il login.

Parole chiave
Breast milk GBS Group-B streptococcus Late-onset disease Recurrent infection
Suggerite dall'AI
Group B Streptococcus Intrapartum antibiotic prophylaxis Latte materno Profilassi antibiotica intrapartum
Classificazione MeSH
Chemical Actions and Uses Pharmacologic Actions Therapeutic Uses Anti-Infective Agents Anti-Bacterial Agents (363)
Therapeutics Drug Therapy Chemoprevention Antibiotic Prophylaxis (47)
Physiological Phenomena Diet, Food, and Nutrition Food Dairy Products Milk Milk, Human (32)
Pathological Conditions, Signs and Symptoms Pathologic Processes Inflammation Systemic Inflammatory Response Syndrome Sepsis Neonatal Sepsis (17)
Pathological Conditions, Signs and Symptoms Pathologic Processes Disease Attributes Recurrence (99)
Bacteria Firmicutes Lactobacillales Streptococcaceae Streptococcus Streptococcus agalactiae (26)
Leggi anche
RI Pagine elettroniche
Screening della colonizzazione vagino-rettale da streptococco di gruppo B in gravidanza
Fangazio M, Melis S, Maglione S, Sfregola G, Barba · 2022
Neonatal Sepsis, Streptococcus agalactiae, Antibiotic Prophylaxis
RI Pagine elettroniche ; Ricerca
Le infezioni da streptococco b in Emilia-Romagna:un problema sempre più pediatrico
· 2007
Neonatal Sepsis, Streptococcus agalactiae, Antibiotic Prophylaxis
RI Aggiornamento
Lo shock settico nei primi tre mesi di vita
Crestani S, Passini E, Spaggiari V, Toffoli C, Bon · 2021
Neonatal Sepsis
RI Pagine elettroniche
Gestione del neonato con sospetta o certa sepsi batterica a esordio precoce
V. Murgia · 2012
Neonatal Sepsis, Streptococcus agalactiae
Bibliografia
1. Berardi A, Rossi C, Guidotti I, Vagnarelli F, Ferrari F. Group B Streptococcus late-onset disease and milk transmission. Acta Paediatr 2013;102:e95. (http://www.ncbi.nlm.nih.gov/pubmed/23252847) 2. Soukka H, Rantakokko-Jalava K, Vähäkuopus S, Ruuskanen O. Three distinct episodes of GBS septicemia in a healthy newborn during the first month of life. Eur J Pediatr 2010;169:1275-7. (http://www.ncbi.nlm.nih.gov/pubmed/20336465) 3. Centers for Disease Control and Prevention (CDC). Perinatal group B streptococcal disease after universal screening recommendations--United States, 2003-2005. MMWR Morb Mortal Wkly Rep 2007;56:701-5. (http://www.ncbi.nlm.nih.gov/pubmed/17637595) 4. Edmond K.M., Kortsalioudaki C., Scott S, et al. Group B streptococcal disease infants aged younger than 3 months: systematic review and meta-analysis. Lancet 2012;369:547-56. (http://www.ncbi.nlm.nih.gov/pubmed/22226047) 5. Edwards, MS, Nizet, V. Group B streptococcal infections. In: Infectious Diseases of the Fetus and Newborn Infant, 7th ed, Remington, JS, Klein, JO, Wilson, CB, et al. (Eds), Elsevier Saunders, Philadelphia 2011:419. 6. Berardi A, Rossi C, Lugli L, et al.; GBS Prevention Working Group, Emilia-Romagna. Group B Streptococcus Late-Onset Disease: 2003-2010. Pediatrics. 2013;13:e361-8. (http://www.ncbi.nlm.nih.gov/pubmed/23296441) 7. Olver WJ, Bond DW, Boswell TC, Watkin SL. Neonatal group B streptococcal disease associated with infected breast milk. Arch Dis Child Fetal Neonatal Ed 2000;83:F48-9. (http://www.ncbi.nlm.nih.gov/pubmed/10873172) 8. Atkins JT, Heresi GP, Coque TM, Baker CJ. Recurrent group B streptococcal disease in infants: Who should receive rifampin? J Pediatr 1998;132:537-9. (http://www.ncbi.nlm.nih.gov/pubmed/9544918) 9. Fernandez M, Rench MA, Albanyan EA, Edwards MS, Baker CJ. Failure of rifampin to eradicate group B streptococcal colonization in infants. Pediatr Infect Dis J 2001;20:371-6. (http://www.ncbi.nlm.nih.gov/pubmed/11332660)